234 results on '"Bonig, H."'
Search Results
2. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
3. Mesenchymal stromal cells for osteonecrosis
4. Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes
5. Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT
6. Retained functional normal and preleukemic HSCs at diagnosis are associated to good prognosis in DNMT3Amut NPM1mut AMLs
7. Frequent whole blood donations select for DNMT3A variants mediating enhanced response to erythropoietin
8. Management of adults and children receiving CAR T- cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
9. Additional file 1 of Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation
10. Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donation
11. RBC depletion from a PBSC graft
12. Effects of the small-molecule inhibitor of integrin α4, TBC3486, on pre-B-ALL cells
13. Hematopoietic stem cell mobilization: updated conceptual renditions
14. Effects of storage temperature on hematopoietic stability and microbial safety of BM aspirates
15. The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor
16. Feasibility of IL-15-activated cytokine-induced killer cell infusions after haploidentical stem cell transplantation
17. Delayed onset of graft-versus-host disease in immunodeficent human leucocyte antigen-DQ8 transgenic, murine major histocompatibility complex class II-deficient mice repopulated by human peripheral blood mononuclear cells
18. Biosimilar filgrastim mobilizes haematopoietic stem cells in healthy volunteer donors with expected efficiency and typical acute adverse effects: interim results of a postauthorization safety study: O177
19. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study
20. Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5·0, a novel, automatic interface-controlled apheresis system: results from the first feasibility trial
21. CELLULAR THERAPY IN HEMATOLOGICAL DISEASES: 3A-S12-01
22. PROPERTIES OF AMD3100 MOBILIZED HEMATOPOIETIC STEM/PROGENITOR CELLS: P-426
23. ANTIBODY SCREENING WITH PAPAIN-TREATED TEST ERYTHROCYTES DETECTS POTENTIALLY TRANSFUSION-RELEVANT ALLO-ANTIBODIES: P-232
24. Cancer-induced inflammation and inflammation-induced cancer in colon: A role for S1P lyase
25. Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey
26. ERBB2/HER2-SPECIFIC NATURAL KILLER CELLS FOR ADOPTIVE IMMUNOTHERAPY OF GLIOBLASTOMA
27. Clonal analysis of multipotent stromal cells derived from CD271+ bone marrow mononuclear cells: functional heterogeneity and different mechanisms of allosuppression
28. Hematopoietic stem cell mobilization: updated conceptual renditions
29. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G‐CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5‐year follow‐up study
30. CO-OPERATION OF IL-1 AND IL-2 ON T-CELL ACTIVATION IN MONONUCLEAR CELL CULTURES
31. Adjuvant treatment of severe acute pancreatitis with C1 esterase inhibitor concentrate after haematopoietic stem cell transplantation
32. Role of Il10 and Il12 in Il2 Induced T-Cell Activation
33. Interleukin-10 Directly Inhibits the Interleukin-6 Production in T-Cells
34. Pediatric Hematology and Oncology at the Heinrich-Heine University Medical School, DUSSELDORF, Germany
35. Blood types of current embryonic stem cell lines are not conducive to culturing 'universal-donor' red blood cells.
36. The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia
37. Current Prophylaxis and Treatment Approaches for Acute Graft-Versus-Host Disease in Haematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukaemia
38. Supportive Care During Pediatric Hematopoietic Stem Cell Transplantation : Prevention of Infections. A Report From Workshops on Supportive Care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)
39. Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
40. Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease.
41. The activating receptor NKp65 is selectively expressed by human ILC3 and demarcates ILC3 from mature NK cells.
42. Cell-Based Therapy by Autologous Bone Marrow-Derived Mononuclear Cells for Bone Augmentation of Plate-Stabilized Proximal Humeral Fractures: A Multicentric, Randomized, Open Phase IIa study.
43. Expression of HLA-DR by mesenchymal stromal cells in the platelet lysate era: an obsolete release criterion for MSCs?
44. Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis.
45. Wnt/β-Catenin-Signaling Modulates Megakaryopoiesis at the Megakaryocyte-Erythrocyte Progenitor Stage in the Hematopoietic System.
46. Response to Haspel and McKenna 'Major incompatible red blood cell transfusions prior to bone marrow transplantation: Not worth the risk'.
47. Automatic generation of alloreactivity-reduced donor lymphocytes and hematopoietic stem cells from the same mobilized apheresis product.
48. Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease.
49. Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.
50. Simulating Space Conditions Evokes Different DNA Damage Responses in Immature and Mature Cells of the Human Hematopoietic System.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.